Head-to-Head Comparison of 18F-PSMA-1007 Positron Emission Tomography/Computed Tomography and Multiparametric Magnetic Resonance Imaging with Whole-mount Histopathology as Reference in Localisation and Staging of Primary Prostate Cancer

Mottet, 2017, EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent, Eur Urol, 71, 618, 10.1016/j.eururo.2016.08.003 Emmett, 2021, The additive diagnostic value of prostate-specific membrane antigen positron emission tomography computed tomography to multiparametric magnetic resonance imaging triage in the diagnosis of prostate cancer (PRIMARY): a prospective multicentre study, Eur Urol, 80, 682, 10.1016/j.eururo.2021.08.002 Soeterik, 2022, Development and external validation of a novel nomogram to predict side-specific extraprostatic extension in patients with prostate cancer undergoing radical prostatectomy, Eur Urol Oncol, 5, 328, 10.1016/j.euo.2020.08.008 de Rooij, 2016, Accuracy of magnetic resonance imaging for local staging of prostate cancer: a diagnostic meta-analysis, Eur Urol, 70, 233, 10.1016/j.eururo.2015.07.029 Somford, 2013, The predictive value of endorectal 3 Tesla multiparametric magnetic resonance imaging for extraprostatic extension in patients with low, intermediate and high risk prostate cancer, J Urol, 190, 1728, 10.1016/j.juro.2013.05.021 Hofman, 2020, Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (ProPSMA): a prospective, randomised, multicentre study, Lancet, 395, 1208, 10.1016/S0140-6736(20)30314-7 Donato, 2019, Improved specificity with 68Ga PSMA PET/CT to detect clinically significant lesions “invisible” on multiparametric MRI of the prostate: a single institution comparative analysis with radical prostatectomy histology, Eur J Nucl Med, 46, 20, 10.1007/s00259-018-4160-7 Berger, 2018, 68Ga-PSMA PET/CT vs. mpMRI for locoregional prostate cancer staging: correlation with final histopathology, Prostate Cancer Prostat Dis, 21, 204, 10.1038/s41391-018-0048-7 Kalapara, 2020, Detection and localisation of primary prostate cancer using 68gallium prostate-specific membrane antigen positron emission tomography/computed tomography compared with multiparametric magnetic resonance imaging and radical prostatectomy specimen pathology, BJU Int, 126, 83, 10.1111/bju.14858 Chen, 2019, Combination of 68Ga-PSMA PET/CT and multiparametric MRI improves the detection of clinically significant prostate cancer: a lesion-by-lesion analysis, J Nucl Med, 60, 944, 10.2967/jnumed.118.221010 Hermsen, 2022, Eur J Nucl Med Mol Imaging, 49, 3929, 10.1007/s00259-022-05827-4 Aide, 2017, EANM/EARL harmonization strategies in PET quantification: from daily practice to multicentre oncological studies, Eur J Nucl Med, 44, 17, 10.1007/s00259-017-3740-2 Turkbey, 2019, Prostate Imaging-Reporting and Data System version 2.1: 2019 update of Prostate Imaging-Reporting and Data System version 2, Eur Urol, 76, 340, 10.1016/j.eururo.2019.02.033 Weinreb, 2016, PI-RADS Prostate Imaging-Reporting and Data System: 2015, version 2, Eur Urol, 69, 16, 10.1016/j.eururo.2015.08.052 Magi-Galluzzi, 2011, International Society of Urological Pathology (ISUP) consensus conference on handling and staging of radical prostatectomy specimens. Working group 3: extraprostatic extension, lymphovascular invasion and locally advanced disease, Mod Pathol, 24, 26, 10.1038/modpathol.2010.158 Kesch, 2017, Intraindividual comparison of 18F-PSMA-1007 PET/CT, multiparametric MRI, and radical prostatectomy specimens in patients with primary prostate cancer: a retrospective, proof-of-concept study, J Nucl Med, 58, 1805, 10.2967/jnumed.116.189233 Statulator. Sample size calculator for estimating a proportion. https://www.statulator.com/SampleSize/ss1P.html. Andreoiu, 2010, Multifocal prostate cancer: biologic, prognostic, and therapeutic implications, Hum Pathol, 41, 781, 10.1016/j.humpath.2010.02.011 Stamey, 2001, Secondary cancers in the prostate do not determine PSA biochemical failure in untreated men undergoing radical retropubic prostatectomy, Eur Urol, 39, 22, 10.1159/000052577 Ahmed, 2009, The index lesion and the origin of prostate cancer, N Engl J Med, 361, 1704, 10.1056/NEJMcibr0905562 Wysock, 2017, Multi-parametric MRI imaging of the prostate-implications for focal therapy, Transl Androl Urol, 6, 453, 10.21037/tau.2017.04.29 Rhee, 2016, Prostate specific membrane antigen positron emission tomography may improve the diagnostic accuracy of multiparametric magnetic resonance imaging in localized prostate cancer, J Urol, 196, 1261, 10.1016/j.juro.2016.02.3000 Woo, 2020, Prostate-specific membrane antigen positron emission tomography (PSMA-PET) for local staging of prostate cancer: a systematic review and meta-analysis, Eur J Hybrid Imaging, 4, 16, 10.1186/s41824-020-00085-9 Hicks, 2018, Diagnostic accuracy of 68Ga-PSMA-11 PET/MRI compared with multiparametric MRI in the detection of prostate cancer, Radiology, 289, 730, 10.1148/radiol.2018180788 Muehlematter, 2019, Diagnostic accuracy of multiparametric MRI versus 68Ga-PSMA-11 PET/MRI for extracapsular extension and seminal vesicle invasion in patients with prostate cancer, Radiology, 293, 350, 10.1148/radiol.2019190687 Thalgott, 2018, One-stop-shop whole-body 68Ga-PSMA-11 PET/MRI compared with clinical nomograms for preoperative T and N staging of high-risk prostate cancer, J Nucl Med, 59, 1850, 10.2967/jnumed.117.207696 Bodar, 2021, Detection of prostate cancer with 18F-DCFPyL PET/CT compared to final histopathology of radical prostatectomy specimens: is PSMA-targeted biopsy feasible? The DeTeCT trial, World J Urol, 39, 2439, 10.1007/s00345-020-03490-8 Ferraro, 2022, Hot needles can confirm accurate lesion sampling intraoperatively using [18F]-PSMA-1007 PET/CT-guided biopsy in patients with suspected prostate cancer, Eur J Nucl Med Mol Imaging, 49, 1721, 10.1007/s00259-021-05599-3 Turkbey, 2010, Prostate cancer: value of multiparametric MR imaging at 3 T for detection—histopathologic correlation, Radiology, 255, 89, 10.1148/radiol.09090475 Fütterer, 2005, Staging prostate cancer with dynamic contrast-enhanced endorectal MR imaging prior to radical prostatectomy: experienced versus less experienced readers, Radiology, 237, 541, 10.1148/radiol.2372041724